AzTrials
AzTrials

Neonatal Abstinence SyndromeNCT03987165

The Effect of Music Therapy on Newborns

A study testing Music Therapy in people with Neonatal Abstinence Syndrome and Substance Withdrawal, Neonatal, run by Tulane University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The clinical study is evaluating the impact of music therapy on neonates, specifically infants with neonatal opioid withdrawal syndrome (NOWS). The goal is to study the effect of music therapy on an infant's behavioral (i.e feeding patterns, sleep patterns, severity of withdrawal) and physiological systems (i.e. Read more about this study

Who is it for?
Ages 1 minute to 1 monthHealthy volunteers can take part
What is being tested?
Music Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteUnited States
Study dates
10 Dec 2018to 7 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 1 month
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Admitted to the NICU or newborn nursery
  • Corrected gestational age 34 weeks or older
  • No identified hearing disorder
  • Do not have a diagnosed developmental disability (i.e. Down Syndrome)
  • Do not have Fetal Alcohol Syndrome
  • Medically cleared to participate in the study
  • Parent or legal guardian able/willing to give consent \& complete surveys.

Who cannot join

  • Corrected gestational age < 34 weeks old
  • Has an identified hearing disorder
  • Has diagnosed developmental disability (i.e. Down syndrome)
  • Has Fetal Alcohol Syndrome
  • Is not medically cleared to participate in the study
  • Parent or legal guardian unable/unwilling to give consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Tulane Lakeside Hospital - Tulane University

    Metairie, Louisiana, 70001

Other trials in United States

About this study

The clinical study is evaluating the impact of music therapy on neonates, specifically infants with neonatal opioid withdrawal syndrome (NOWS). The goal is to study the effect of music therapy on an infant's behavioral (i.e feeding patterns, sleep patterns, severity of withdrawal) and physiological systems (i.e. heart rate, respiratory rate). The investigators are also studying the impact of music therapy on the infant's utilization of resources (i.e. total opioid usage and total length of stay).

Read the detailed description

The research will be carried out at the Tulane Lakeside Hospital for Women and Children. Caregivers of eligible infants will be approached by the medical team during the infants stay at the hospital and asked if they would be willing to hear more about this study. Fliers will be provided and also posted so that pregnant mothers or mothers who see the flier can also find out more about the study and decide to participate. Mothers may contact the study directly. Alternatively the medical team will ask the caregiver if the research team can contact them to set up a time to talk to them about the study. If the caregiver agrees then the contact information for the caregiver will be provided to the research team who will schedule an in person meeting to go over the protocol and obtain consent. The PI or one of the research team will meet with the infant's parent/legal guardian, review the study explaining all music therapy methods that will be used, explain the risks and benefits of participation, answer all questions and ask for consent to allow infant to participate in the study, to allow researchers to audio-video record the music therapy session, and to allow researchers to review medical records of the parent/legal guardian and infant to obtain information for the Data Collection Form regarding the infant's gestational age, race, ethnicity, gender, diagnosis, pregnancy and delivery complications, results of the any laboratory work, infant medication history, and daily withdrawal Scores over the study period, or until infant's medical discharge. Infants will still be able to participate in the study if the caregiver does not consent to audio-visual recording. Informed consent and HIPAA forms will be obtained electronically via REDCap, including electronic capture of the mother's signature as well as consenting research assistant's signature, and the original electronic copy of the informed consent and HIPAA forms are maintained in the REDCap database, accessible only by study personnel as listed in the IRB.

After informed consent has been obtained, the parent/legal guardian will complete the following questionnaires and surveys: Adverse Childhood Experiences Scale (ACE), Duke Functional Support System Questionnaire (FSSQ), Edinburgh Depression Scale (EDS), Postpartum Bonding Questionnaire (PBQ), Prenatal Life Events Scale (PLES Revised), Perinatal Stress Scale:NICU (PSS:NICU), the Coronavirus Anxiety Scale (CAS) and the COVID-19 Exposure and Family Impact Survey (CEFIS). The parent/legal guardian does not have to be present, but can be present for all music sessions.

Music therapy interventions will take place over the course of five days. The anticipated length of stay in the hospital for infants with NOWS or iatrogenic exposure to opioids is 21 days and for healthy full term infants is two to three days; however per institutional protocol, infants exposed to long-acting opioids in utero could be monitored up to 72-96 hours prior to discharge to monitor for signs of withdrawal. We will continue study procedures until completion of the music therapy treatment schedule, or until infant's discharge from the hospital if infant is discharged before completing all music therapy sessions. We will not interfere with standard medical care and therefore recognize that infants without NOWS will receive less days of music therapy in general, however the consistent daily administration of music therapy will provide some ability.

This study will use a cross-over design with participants undergoing music therapy once daily (either morning or afternoon) using a Song of Kin, defined as a familiar song used to lull the infant to sleep. If Song of Kin is not provided, the default lullaby will be "Twinkle Twinkle Little Star." In addition, there will be sessions of standard nursing care with no treatment intervention (CON). Counterbalancing will be achieved by assigning a different order of presentation of conditions for each group. Each day, infants will receive a music therapy session lasting up to 20 minutes using the above mentioned technique. The music therapy session will be in the morning or afternoon depending upon which treatment group the participant is assigned to. There will not be any visits by the music therapist during sessions that the infant is to receive standard nursing care with no treatment intervention (morning/afternoon). Over the 5 day period (all week, including weekends) participants will experience conditions in the following order (with music therapy sessions designated as "MT" and control data only designated as "C"):

Condition A:

Day 1 (AM - music therapy, PM - control) Day 2 (AM - control, PM - music therapy) Day 3 (AM - music therapy, PM - control) Day 4 (AM - control, PM - music therapy) Day 5 (AM - music therapy, PM - control)

Condition B:

Day 1 (AM - control, PM - music therapy) Day 2 (AM - music therapy, PM - control) Day 3 (AM - control, PM - music therapy) Day 4 (AM - music therapy, PM - control) Day 5 (AM - control, PM - music therapy)

Prior to the first session, a research assistant will place electrodes on the infant so that they study team can gather sympathetic and parasympathetic response non-invasively using MindWare Portable Lab System (MindWare Technologies, Gahanna, Ohio). These electrodes will remain on the infant throughout each session and be removed via adhesive removing pads following each session's data collection. This will minimize discomfort to the infant secondary to electrode removal and minimize risk of skin irritation by leaving electrodes in place for a proloned period of time. The medical team will complete the standard hospital withdrawal scoring scale for each infant with NOWS or suspected to have NOWS following unit policy. Withdrawal scores will not be collected on newborns who are not thought to have NOWS. Data related to the NOWS symptoms and medical conditions will be obtained from medical records. Additional observational data before and after the music sessions will be collected by the research assistant, including descriptions of where the session is conducted (isolette/bassinette), activity level, vital signs, sleep/wake pattern, sucking pattern, and any other observed behaviors throughout the session.

The following research materials and data collection tools are submitted with this IRB package: Data Collection Form and Key, Medical Abstraction Form, Music Therapy Session Notes, Support System Questionnaire (FSSQ), Edinburgh Depression Scale (EDS), Postpartum Bonding Questionnaire (PBQ), Prenatal Life Events Scale (PLES Revised), Adverse Childhood Experiences (ACE) Scale, Duke Functional Support System Questionnaire (FSSQ), Perinatal Stress Scale:NICU (PSS:NICU), the Coronavirus Anxiety Scale (CAS) and the COVID-19 Exposure and Family Impact Survey (CEFIS) and Research Code Identification Sheet.

Being tested
Music Therapy
Keywords
Neonatal Opioid Withdrawal Syndrome
Medical subject headings
Neonatal Abstinence Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Music TherapyOther

    Music therapy will be conducted once daily using a Song of Kin, a familiar song used to lull the infant to sleep. If no Song of Kin is provided, "Twinkle Twinkle Little Star" will be the default lullaby.

Study groups in NCT03987165
Study groupRoleWhat they receive
Music TherapyExperimentalMusic therapy by a certified music therapist will be delivered to infants over a period of 5 days. There will be two periods of data collection each day, one in the morning and one in the afternoon. Each baby will receive music therapy during one of these time points, with each baby serving as their own control during the second timepoint.
Receives: Other: Music Therapy
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Heart Rate

    Infant's heart rate before, during and after music therapy and during the control session.

    Measured: Change in average heart rate over the 20 minute sessions (both control and music therapy)

  2. Change in Heart Rate Variability

    Infant's heart rate variability before, during and after music therapy and during the control session.

    Measured: Change in average heart rate variability over the 20 minute sessions (both control and music therapy)

  3. Change in Sleeping Patterns

    Basic parameters of sleeping - Type of sleep during control and intervention periods, including but not limited to, active/alert, quiet alert, sleeping. We will monitor time from end of feeding to start of sleep.

    Measured: Change in phase of sleep over the 20 minute sessions (both control and music therapy)

  4. Change in Feeding Patterns

    Time between the end of feeding and the onset of sleeping, with music therapy to be conducted during feeding.

    Measured: Time from feeding to onset of sleep over the 20 minute session (both control and music therapy)

  5. Morphine Utilization

    Total cumulative dosage of morphine required during the infant's hospitalization as well as the total number of days on morphine. We will also determine the day of the maximum morphine dosage required by the infant.

    Measured: From day of birth through day of discharge, up to 6 months

  6. Total Length of Stay

    The total number of days the infant was hospitalized, from day of birth to day of discharge from the NICU

    Measured: From day of birth through day of discharge, up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2019
  2. Study start10 Dec 2018
  3. Primary completion7 Aug 2024
  4. Study completion7 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
cross over design with each baby serving as its own control
Masking
None (open label)
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03987165
Sponsor's protocol ID
1043190
Status last verified
Aug 2024
First submitted
6 Jun 2019
Last updated
9 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pahl A, Young L, Buus-Frank ME, Marcellus L, Soll R. Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013217. doi: 10.1002/14651858.CD013217.pub2.

    PubMed 33348423

Questions about this trial

What is this clinical trial studying?

A study testing Music Therapy in people with Neonatal Abstinence Syndrome and Substance Withdrawal, Neonatal, run by Tulane University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Heart Rate (time frame: Change in average heart rate over the 20 minute sessions (both control and music therapy)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03987165, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in